In 1915, pathologist Maude Abbott systematically described congenital heart defects – a milestone that demonstrated how careful early detection can save lives. This principle also applies to urology today: identifying diseases early, before they drain energy, performance, and years of life. Pioneering women like Abbott paved the way to understand diagnosis not as a reaction but as a strategy. This is exactly what men need today for their prostate, bladder, and kidneys – proactive prevention as a performance asset.

Urological prevention includes regular checks of the prostate, bladder, and kidneys – organs that indirectly govern hormonal balance, metabolism, and regeneration. The PSA levelProstate-specific antigen in the blood; increases with prostate diseases, but not exclusively with cancer is a signal, not a verdict. The eGFRestimated glomerular filtration rate; a measure of kidney function indicates how well the kidneys filter blood. Proteinuriaprotein in urine; an early sign of kidney damage indicates filter stress. For high performers, this means: stable kidney function keeps blood pressure, acid-base balance, and recovery in check; a healthy prostate protects against painful inflammation, nocturia, and performance drops due to poor sleep.

Early detection affords reserves. In men, high alcohol consumption is linked to measurable kidney losses: Starting from about 40 g of ethanol per day, the risk of a significant decline in eGFR and proteinuria increases – both are markers for progressive kidney weakness, which later affects blood pressure, endurance, and recovery ^[1]. Experimental and clinical data further suggest that alcohol stresses the kidneys directly — through mitochondrial dysfunction, oxidative stress, and systemic inflammation; indirectly, impaired gut barrier, liver, and circulatory functions exacerbate kidney supply ^[2]. In prostate cancer, PSA remains a useful signal but becomes more precise when modern markers are added: New tests like S2,3PSA can help avoid unnecessary biopsies, especially when combined with an unremarkable MRI, without overlooking relevant tumors ^[3]. Another strong factor: avoiding tobacco significantly lowers the risk of renal cell carcinoma; analyses show a notably lower risk among men compared to smokers ^[4].

A large Japanese cohort study with regular check-ups revealed a clear dose-response relationship for men between daily alcohol consumption above approximately 40 g and accelerated decline in kidney function as well as more frequent proteinuria. Practically speaking: consumption above this threshold increases the risk for clinically relevant kidney damage – a direct threat to performance and longevity ^[1]. Additionally, a recent review summarizes the biological mechanisms through which alcohol can harm the kidneys: from mitochondrial energy depletion to inflammation-driven circulatory disturbances; it calls for more sensitive biomarkers to timely detect early damage – a hint that "normal" lab values can be misleading under high stress ^[2]. In prostate diagnostics, the clinical introduction of the S2,3PSA marker shows that biomarkers combined with imaging allow for smarter decisions. In a patient cohort, the marker was elevated in significant cancer cases and could – together with an unremarkable MRI – spare unnecessary biopsies. For men, this means: more precise assessments, fewer interventions, yet high oncological safety ^[3]. Finally, a meta-analysis emphasizes that quitting smoking significantly reduces the risk of renal cell carcinoma, particularly in men – a strong, modifiable factor with direct relevance to urological prevention ^[4].

- Smart management of PSA: From age 45 (earlier if there is a family history), get your PSA level checked and discuss the combination of PSA, prostate volume, MRI, and – if available – extended markers like S2,3PSA with your urologist. Goal: avoid unnecessary biopsies, find relevant tumors early ^[3].
- Consciously limit alcohol: Keep daily consumption below 20–30 g of ethanol; ideally, have alcohol-free days and weekly goals. Men with ≥40 g/day show more frequent eGFR declines and proteinuria – an early path to kidney weakness ^[1]. Consider: mechanistic evidence supports direct and indirect kidney damage from alcohol; normal creatinine levels can obscure early damage ^[2]. While some cross-sectional data report better eGFR in drinkers, study design bias does not allow for reassurance – in the long term, the risks outweigh the benefits ^[5].
- Smoking cessation as cancer prevention: Avoid or quit tobacco consistently. This significantly lowers your risk of renal cell carcinoma, particularly as a man ^[4]. Utilize behavioral therapy programs, nicotine replacement, or medical treatment – the earlier, the more years of life and energy you regain.
- Track kidney function: Have eGFR and urine checked for protein annually, especially during high workload, intense training phases, or hypertension. Early-detected proteinuria allows timely adjustments regarding alcohol, blood pressure, hydration, and training ^{[1] [2]}.

Urological prevention is not a mandatory appointment but a performance lever: smart diagnostics, sober management of alcohol, and smoking cessation protect the prostate and kidneys – and thus sleep, energy, and longevity. Those who act now shift the aging curve in favor of vitality and focus.